0001811468-23-000002.txt : 20231002 0001811468-23-000002.hdr.sgml : 20231002 20231002112441 ACCESSION NUMBER: 0001811468-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 EFFECTIVENESS DATE: 20231002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atsena Therapeutics, Inc. CENTRAL INDEX KEY: 0001811468 IRS NUMBER: 845181493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493532 FILM NUMBER: 231298406 BUSINESS ADDRESS: STREET 1: 8 DAVIS DRIVE, SUITE 300 CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 984-261-2001 MAIL ADDRESS: STREET 1: 8 DAVIS DRIVE, SUITE 300 CITY: DURHAM STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001811468 Atsena Therapeutics, Inc. 8 DAVIS DRIVE, SUITE 300 DURHAM NC NORTH CAROLINA 27709 984-261-2001 DELAWARE VectorEyes Therapeutics, Inc. None Corporation true 2019 Patrick Ritschel c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Executive Officer Director Michael Dial c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Jacqueline Grant c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Shannon Boye c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Christina Isacson c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director James Healy c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Jennifer Wellman c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Elizabeth Leiderman c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Executive Officer Biotechnology Decline to Disclose 06b false 2023-08-28 false true false 0 32000000 24474387 7525613 false 10 0 0 0 false Atsena Therapeutics, Inc. /s/ Patrick Ritschel Patrick Ritschel Chief Executive Officer 2023-10-02